Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma

References

• Rasmussen JH, Vogelius IR, Fischer BM, Friborg J, Aznar MC, Persson GF, et al. Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma. Head Neck Epub 2014 May 7.
   Google Scholar
• Cullen KJ, Schumaker L, Nikitakis N, Goloubeva O, Tan M, Sarlis NJ, et al. beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: A companion analysis of the TAX 324 trial. J Clin Oncol 2009;27:6222–8.
   PubMed Web of Science ®Google Scholar
• Wu Y, Posner MR, Schumaker LM, Nikitakis N, Goloubeva O, Tan M, et al. Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: An analysis of the TAX 324 trial. Cancer 2012;118: 1811–7.
   PubMed Web of Science ®Google Scholar
• Buffa FM, Bentzen SM, Daley FM, Dische S, Saunders MI, Richman PI, et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res 2004;10: 3745–54.
   PubMed Web of Science ®Google Scholar
• Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol 2010;11:781–9.
   PubMed Web of Science ®Google Scholar
• Oliveira LR, Ribeiro-Silva A. Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2011;40:298–307.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 2013;12:931–47.
   PubMed Web of Science ®Google Scholar
• Tew KD, Manevich Y, Grek C, Xiong Y, Uys J, Townsend DM. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 2011;51:299–313.
   PubMed Web of Science ®Google Scholar
• Parker AL, Kavallaris M, McCarroll JA. Microtubules and their role in cellular stress in cancer. Front Oncol 2014;4:153.
   PubMedGoogle Scholar
• Ohishi Y, Oda Y, Basaki Y, Kobayashi H, Wake N, Kuwano M, et al. Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol Oncol 2007;105:586–92.
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Perri F, Buonaguro L, Ionna F, Buonaguro FM, Caponigro F. HPV-related oropharyngeal cancers: From pathogenesis to new therapeutic approaches. Cancer Lett 2014;351:198–205.
   PubMed Web of Science ®Google Scholar
• Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000;182:311–22.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Atasoy BM, Daley FM, Dische S, Richman PI, Saunders MI, et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 2005;23:5560–7.
   PubMed Web of Science ®Google Scholar
• Ang KK, Berkey B a, Tu X, Zhang H-Z, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350–6.
   PubMed Web of Science ®Google Scholar
• Rasmussen J, Vogelius IR, Fischer M, Aznar MC, Håkansson K, Persson GF, et al. Prognostic value of 18F-Fluorodeoxyglucose SUVmax in head-and-neck cancer depends on the gross tumor volume. Int J Radiat Oncol 2013;87:S473.
   Web of Science ®Google Scholar
• β Tubulin (JDR.3B8): sc-58882. Datasheet n.d. [cited 2014 Sept 22]. Available from: http://datasheets.scbt.com/sc-58882.pdf.
   Google Scholar
• Lassen P. DAHANCA/EORTC guidelines for scoring and classification of p16-immunohistochemistry in HPV-related oropharyngeal cancer 2012. [cited 2015 May 10]. Available from: http://www.dahanca.dk/get_media_file.php?mediaid = 322
   Google Scholar
• Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155–68.
   PubMed Web of Science ®Google Scholar
• Hoeben BAW, Bussink J, Troost EGC, Oyen WJG, Kaanders JHAM. Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer. Acta Oncol 2013;52:1257–71.
   PubMed Web of Science ®Google Scholar
• Baschnagel AM, Williams L, Hanna A, Chen PY, Krauss DJ, Pruetz BL, et al. C-met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation. Int J Radiat Oncol Biol Phys 2014;88:701–7.
   PubMed Web of Science ®Google Scholar
• Hoeben BAW, Starmans MHW, Leijenaar RTH, Dubois LJ, van der Kogel AJ, Kaanders JHAM, et al. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors. BMC Cancer 2014;14:130.
   PubMed Web of Science ®Google Scholar
• Shepherd T, Teras M, Beichel RR, Boellaard R, Bruynooghe M, Dicken V, et al. Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy. IEEE Trans Med Imaging 2012;31:2006–24.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, et al. Interaction of quantitative 18F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. Head Neck Epub 2014 Oct 19.
   PubMed Web of Science ®Google Scholar